On Biostatistics and Clinical Trials

CQ's web blog on the issues in biostatistics and clinical trials.

Monday, May 30, 2011

Differences between SOPs and WPs

›
Working in industry setting (versus academic), we all understand that it is critical for us to be familiar with the Standard Operating P...
Saturday, May 14, 2011

I-Spy 2 Trial - a study with fancy name and fancy design

›
If you see the term “I-spy”, you would typically think something related to movie, kids game or TV series. Recently, I-spy has been linked t...
Friday, April 29, 2011

Mobile phone text message used in clinical trial?

›
Recent discussions with my friends in China surprised me a little bit. They are way ahead in applying the advanced technology in public heal...
1 comment:
Saturday, April 16, 2011

Emerging Statistical Issues in the Conduct and Monitoring of Clinical Trials

›
This Wednesday, I had a chance to attend “University of Pennsylvania Annual Conference on Statistical Issues in Clinical Trials”. The topi...
1 comment:
Saturday, April 09, 2011

Sparse sample and population pharmacokinetics

›
In drug development, it is necessary to understand the pharmacokinetics profiles (or time concentration profiles) of the experimental drug a...
1 comment:
Friday, March 11, 2011

Use of SF-36 in Clinical Trials

›
The SF-36 is a multi-purpose, short-form health survey with 36 questions. SF-36 is one of the most popular instruments for generic health su...
4 comments:
Thursday, March 03, 2011

Incidence Rate (IR) – How could this be wrongly calculated?

›
I am very surprised to see how a simple concept of ‘incidence rate’ can be wrongly calculated in documents  submitted to regulatory agencies...
7 comments:
Friday, February 25, 2011

Study Center Pooling Strategy in Multicenter Clinical Trials

›
Pooling the study center for statistical analysis purpose is rather an old issue. However, we can still see the discussion o f study center ...
6 comments:
Tuesday, February 08, 2011

Guidelines for Blood Volumes in Clinical Trials (Especially in Pediatric Clinical Trials)

›
Nowadays, the clinical study protocols are becoming more and more complicated and require more and more blood sample draws for various purpo...
4 comments:
Friday, January 28, 2011

Edit check - a critical step to ensure the data quality during clincial trials

›
In clinical trial, one critical task is to ensure that the data collected or data entered into the system / database is valid, correct, and ...
11 comments:
Sunday, January 23, 2011

Regulatory Guidance on Source Data in EDC Trials

›
When we move toward the clinical studies using electronic data capture, the ‘source data’ or ‘source document’ has been an issue. Unlike the...
1 comment:
Tuesday, January 11, 2011

FDA's New Website for Industry

›
Have you noticed the changes in the design of FDA website ( http://www.fda.gov/ ) recently? Last August, I mentioned the FDA's initiati...
Sunday, January 02, 2011

Agreement Statistics and Kappa

›
In clinical trial and medical research, we often have a situation where two different measures/assessments are performed on the same sample,...
2 comments:
Monday, December 27, 2010

Bootstrap and SAS

›
In statistics, bootstrapping is a resampling technique used to obtain estimates of summary statistics. In clinical trials, bootstrapping te...
2 comments:
‹
›
Home
View web version

About Me

My photo
Web blog from Dr. Deng
Chapel Hill, NC, United States
邓春勤 A Medical Doctor turned into Biostatistician in Clinical Trial and Drug Development Industry
View my complete profile
Powered by Blogger.